You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CCR5-tropic

Showing 1 - 25 of 1,839
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial in United States (PRO 140 (350 mg), PRO 140 (525 mg), PRO 140 (700 mg))

Active, not recruiting
  • HIV
  • PRO 140 (350 mg)
  • +2 more
  • La Mesa, California
  • +11 more
Jan 13, 2022

CCR5, Microsatellite Stable, Metastatic Trial (700mg leronlimab weekly dose, 80mg Regorafenib at week 1, 120mg Regorafenib at

Withdrawn
  • CCR5
  • +3 more
  • 700mg leronlimab weekly dose
  • +3 more
  • (no location specified)
Feb 15, 2023

Maraviroc In Patients For HIV Patients

Completed
Has Results
  • CCR5-tropic HIV-1 Infection
  • CELSENTRI® Tablets
  • (no location specified)
Dec 6, 2019

Solid Tumor, Adult Trial in San Francisco (Leronlimab)

Active, not recruiting
  • Solid Tumor, Adult
  • San Francisco, California
    Quest Clinical Research
Jun 30, 2022

Triple Negative Breast Tumors Trial in San Francisco, Chicago (350 mg leronlimab, 525 mg leronlimab, 700 mg leronlimab)

Active, not recruiting
  • Triple Negative Breast Neoplasms
  • 350 mg leronlimab
  • +4 more
  • San Francisco, California
  • +1 more
Mar 18, 2022

Metastatic Colorectal Cancer, MSS Trial in Heidelberg (Pembrolizumab, Maraviroc)

Completed
Has Results
  • Metastatic Colorectal Cancer
  • MSS
  • Heidelberg, Germany
    National Center for Tumor Diseases, University Hospital Heidelbe
May 17, 2022

Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC), Pancreatic Ductal Adenocarcinoma Trial in Baltimore (Stereotactic Body

Recruiting
  • Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)
  • Pancreatic Ductal Adenocarcinoma
  • Stereotactic Body Radiation (SBRT)
  • +3 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Jan 28, 2022

HIV Trial in Puerto Rico, United States (Vicriviroc)

Completed
Has Results
  • HIV Infections
  • San Diego, California
  • +8 more
Nov 3, 2021

HIV Trial in Cincinnati (SB-728-T, Expanded unmodified autologous CD4+ T cells)

Active, not recruiting
  • HIV Infections
  • SB-728-T
  • Expanded unmodified autologous CD4+ T cells
  • Cincinnati, Ohio
    University of Cincinnati
Jan 1, 2022

HIV Trial in Puerto Rico, United States (PRO 140, Placebo, Optimized Background Regimen)

Completed
  • HIV
  • PRO 140
  • +2 more
  • Fountain Valley, California
  • +36 more
Sep 28, 2021

Human Immunodeficiency Virus Trial in Worldwide (Maraviroc)

Active, not recruiting
Has Results
  • Human Immunodeficiency Virus
  • Los Angeles, California
  • +40 more
Apr 17, 2020

Hiv, Human Immunodeficiency Virus Trial (PRO 140 SC injections)

Active, not recruiting
  • Hiv
  • Human Immunodeficiency Virus
  • PRO 140 SC injections
  • (no location specified)
Sep 28, 2021

Metastatic Triple-Negative Breast Carcinoma Trial (Leronlimab)

No longer available
  • Metastatic Triple-Negative Breast Carcinoma
  • (no location specified)
Jan 13, 2022

HIV Trial in United States (SB-728mR-HSPC Infusion 3 days following busulfan conditioning)

Active, not recruiting
  • HIV
  • SB-728mR-HSPC Infusion 3 days following busulfan conditioning
  • Duarte, California
  • +4 more
Mar 7, 2022

Cord Blood Transplantation With CCR5?32 Donor Cells on HIV

Active, not recruiting
  • HIV Infection
    • New York, New York
      Weill Cornell Uptown Clinical Research Site (7803)
    Feb 3, 2022

    NSCLC, Hepatocellular Carcinoma Trial in New York (Nivolumab, BMS-813160, BMS-986253)

    Recruiting
    • Non-small Cell Lung Cancer
    • Hepatocellular Carcinoma
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Oct 14, 2021

    Advanced Solid Tumors Trial in Canada, Singapore, United States (BAY3375968, Pembrolizumab)

    Not yet recruiting
    • Advanced Solid Tumors
    • Chicago, Illinois
    • +4 more
    Sep 9, 2022

    Pancreatic Ductal Adenocarcinoma Trial in Saint Louis (BMS-813160, Nivolumab, Gemcitabine)

    Active, not recruiting
    Has Results
    • Pancreatic Ductal Adenocarcinoma
    • Saint Louis, Missouri
      Washington University School of Medicine
    Dec 8, 2022

    Hiv Trial in Philadelphia (CD4 CAR+CCR5 ZFN T-cells)

    Active, not recruiting
    • Hiv
    • CD4 CAR+CCR5 ZFN T-cells
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Jan 6, 2022

    HIV-1-infection Trial in San Francisco (PRO 140 350, PRO 140 525, PRO 140 700)

    Active, not recruiting
    • HIV-1-infection
    • PRO 140 350
    • +2 more
    • San Francisco, California
      Quest Clinical Research
    Mar 4, 2022

    HIV Infection, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Plasmablastic Lymphoma Trial in United States (procedure, drug,

    Recruiting
    • HIV Infection
    • +10 more
    • Autologous Hematopoietic Stem Cell Transplantation
    • +7 more
    • La Jolla, California
    • +3 more
    Dec 7, 2022

    Hematologic Malignancy Trial in Philadelphia (Maraviroc 300 mg)

    Completed
    Has Results
    • Hematologic Malignancy
    • Maraviroc 300 mg
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Dec 16, 2020

    Human Immunodeficiency Virus (HIV) Trial in United States (SB-728mR-T, Cyclophosphamide)

    Completed
    Has Results
    • Human Immunodeficiency Virus (HIV)
    • San Francisco, California
    • +4 more
    Mar 17, 2021

    HIV, Human Immunodeficiency Virus Trial in San Francisco (PRO 140 350mg weekly SQ injection.)

    Completed
    • HIV
    • Human Immunodeficiency Virus
    • PRO 140 350mg weekly SQ injection.
    • San Francisco, California
      Quest Clinical Research
    Sep 28, 2021

    AIDS-Related Burkitt Lymphoma, AIDS-Related Diffuse Large B-cell Lymphoma, AIDS-Related Plasmablastic Lymphoma Trial run by the

    Active, not recruiting
    • AIDS-Related Burkitt Lymphoma
    • +5 more
    • Bethesda, Maryland
      NCI Lymphoid Malignancies Branch
    Jul 31, 2022